Dana Small Cap Equity

As of: August 29, 2018

Dana Epiphany ESG Small Cap Equity Fund

Fund Information

as of 9/30/21
SYMBOL DSCIX
INCEPTION DATE 11/2/15
BENCHMARK Russell 2000 Index
TOTAL FUND AUM $16.5 MM
TOTAL FIRM AUM $7.3 BN
MIN. INVESTMENT $5,000
NET EXPENSE RATIO 0.95%
GROSS EXPENSE RATIO 1.88%
NUMBER OF HOLDINGS 60 – 65
TARGET CASH POSITION 0 – 1%
INDIVIDUAL SECURITY LIMIT < 4%
SECTOR LIMITS SECTOR NEUTRAL

Data source: Morningstar Direct; The Adviser has contractually agreed to waive its management fee and/or reimburse certain operating expenses through 2/28/2022, so that Total Annual Operating Expenses does not exceed 0.95% for the Fund. Time period for statistical calculations is from fund inception to 6/30/21.

Top Holdings

as of 9/30/21, subject to change. Current and future portfolio holdings are subject to risk.
Ovintiv, Inc. 2.33%
Horizon Therapeutics PLC 2.33%
Blueprint Medicines Corp 2.16%
Omnicell, Inc. 2.15%
Group 1 Automotive, Inc. 2.15%
Perficient, Inc. 2.09%
Envista Holdings Corp 2.08%
CONMED Corp 2.07%
Rexnord Corp 2.06%
Aurinia Pharmaceuticals, Inc. 2.04%

 

The Dana Funds are available in a number of account types.
Please contact us to learn more.